ArticleCancer cell international2021
Correction to: Post treatment NLR is a predictor of response to immune checkpoint inhibitor therapy in patients with esophageal squamous cell carcinoma.
Xiaobin Wu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.